|
1
|
Herring JA: Management of Perthes'
disease. J Pediatr Orthop. 16:1–2. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beckmann R, Shaheen H, Kweider N, Ghassemi
A, Fragoulis A, Hermanns-Sachweh B, Pufe T, Kadyrov M and Drescher
W: Enoxaparin prevents steroid-related avascular necrosis of the
femoral head. ScientificWorldJournal. 2014:3478132014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nishida K, Yamamoto T, Motomura G,
Jingushi S and Iwamoto Y: Pitavastatin may reduce risk of
steroid-induced osteonecrosis in rabbits: A preliminary
histological study. Clin Orthop Relat Res. 466:1054–1058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takano-Murakami R, Tokunaga K, Kondo N,
Ito T, Kitahara H, Ito M and Endo N: Glucocorticoid inhibits bone
regeneration after osteonecrosis of the femoral head in aged female
rats. Tohoku J Exp Med. 217:51–58. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Samara S, Dailiana Z, Chassanidis C,
Koromila T, Papatheodorou L, Malizos KN and Kollia P: Expression
profile of osteoprotegerin, RANK and RANKL genes in the femoral
head of patients with avascular necrosis. Exp Mol Pathol. 96:9–14.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weinstein RS, Jilka RL, Parfitt AM and
Manolagas SC: Inhibition of osteoblastogenesis and promotion of
apoptosis of osteoblasts and osteocytes by glucocorticoids.
Potential mechanisms of their deleterious effects on bone. J Clin
Invest. 102:274–282. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kerachian MA, Séguin C and Harvey EJ:
Glucocorticoids in osteonecrosis of the femoral head: A new
understanding of the mechanisms of action. J Steroid Biochem Mol
Biol. 114:121–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yun SI, Yoon HY, Jeong SY and Chung YS:
Glucocorticoid induces apoptosis of osteoblast cells through the
activation of glycogen synthase kinase 3beta. J Bone Miner Metab.
27:140–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SJ, Bahk WJ, Chang CH, Jang JD and
Suhl KH: Treatment of osteonecrosis of the femoral head using
autologous cultured osteoblasts: A case report. J Med Case Rep.
2:582008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Wijnen AJ, van de Peppel J, van
Leeuwen JP, Lian JB, Stein GS, Westendorf JJ, Oursler MJ, Im HJ,
Taipaleenmäki H, Hesse E, et al: MicroRNA functions in osteogenesis
and dysfunctions in osteoporosis. Curr Osteoporos Rep. 11:72–82.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lian JB, Stein GS, van Wijnen AJ, Stein
JL, Hassan MQ, Gaur T and Zhang Y: MicroRNA control of bone
formation and homeostasis. Nat Rev Endocrinol. 8:212–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyaki S and Asahara H: Macro view of
microRNA function in osteoarthritis. Nat Rev Rheumatol. 8:543–552.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia Z, Chen C, Chen P, Xie H and Luo X:
MicroRNAs and their roles in osteoclast differentiation. Front Med.
5:414–419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goldring MB and Marcu KB: Epigenomic and
microRNA-mediated regulation in cartilage development, homeostasis,
and osteoarthritis. Trends Mol Med. 18:109–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taipaleenmäki H, Hokland Bjerre L, Chen L,
Kauppinen S and Kassem M: Mechanisms in endocrinology: micro-RNAs:
Targets for enhancing osteoblast differentiation and bone
formation. Eur J Endocrinol. 166:359–371. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Inose H, Ochi H, Kimura A, Fujita K, Xu R,
Sato S, Iwasaki M, Sunamura S, Takeuchi Y, Fukumoto S, et al: A
MicroRNA regulatory mechanism of osteoblast differentiation. Proc
Natl Acad Sci USA. 106:20794–20799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu G, Luo G, Bo Z, Liang X, Huang J and
Li D: Impaired osteogenic differentiation associated with
connexin43/microRNA-206 in steroid-induced avascular necrosis of
the femoral head. Exp Mol Pathol. 101:89–99. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krichevsky AM and Galina G: miR-21: A
small multi-faceted RNA. J Cell Mol Med. 13:39–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Loh PG, Yang HS, Walsh MA, Wang Q, Wang X,
Cheng Z, Liu D and Song H: Structural basis for translational
inhibition by the tumour suppressor Pdcd4. EMBO J. 28:274–285.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu H, Shi L, Qi G, Zhao S, Gao Y and Li Y:
Gypenoside protects cardiomyocytes against ischemia-reperfusion
injury via the inhibition of mitogen-activated protein kinase
mediated nuclear factor kappa B pathway in vitro and in vivo. Front
Pharmacol. 7:1482016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sugatani T, Vacher J and Hruska KA: A
microRNA expression signature of osteoclastogenesis. Blood.
117:3648–3657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng JC, Lam TP and Ng BK: Prognosis and
prognostic factors of Legg-Calve-Perthes disease. J Pediatr Orthop.
31 2 Suppl:S147–S151. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ito H, Matsuno T and Kaneda K: Prognosis
of early stage avascular necrosis of the femoral head. Clin Orthop
Relat Res. 149–157. 1999.PubMed/NCBI
|
|
25
|
Ohzono K, Saito M, Takaoka K, Ono K, Saito
S, Nishina T and Kadowaki T: Natural history of nontraumatic
avascular necrosis of the femoral head. J Bone Joint Surg Br.
73:68–72. 1991.PubMed/NCBI
|
|
26
|
Hao C, Yang S, Xu W, Shen JK, Ye S, Liu X,
Dong Z, Xiao B and Feng Y: MiR-708 promotes steroid-induced
osteonecrosis of femoral head, suppresses osteogenic
differentiation by targeting SMAD3. Sci Rep. 6:225992016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bai R, Feng W, Liu WL, Zhao ZH, Zhao AQ,
Wang Y, Wang WX, Sun L, Wu LS and Cui SH: Roles of osteocyte
apoptosis in steroid-induced avascular necrosis of the femoral
head. Genet Mol Res. 15:2016. View Article : Google Scholar
|
|
28
|
Meng YB, Li X, Li ZY, Zhao J, Yuan XB, Ren
Y, Cui ZD, Liu YD and Yang XJ: microRNA-21 promotes osteogenic
differentiation of mesenchymal stem cells by the PI3K/β-catenin
pathway. J Orthop Res. 33:957–964. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su X, Liao L, Shuai Y, Jing H, Liu S, Zhou
H, Liu Y and Jin Y: MiR-26a functions oppositely in osteogenic
differentiation of BMSCs and ADSCs depending on distinct activation
and roles of Wnt and BMP signaling pathway. Cell Death Dis.
6:e18512015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Candini O, Spano C, Murgia A, Grisendi G,
Veronesi E, Piccinno MS, Ferracin M, Negrini M, Giacobbi F, Bambi
F, et al: Mesenchymal progenitors aging highlights a miR-196 switch
targeting HOXB7 as master regulator of proliferation and
osteogenesis. Stem Cells. 33:939–950. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jansen AP: A novel transformation
suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB
or ODC transactivation. Oncogene. 20:669–676. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jansen AP, Camalier CE, Stark C and
Colburn NH: Characterization of programmed cell death 4 in multiple
human cancers reveals a novel enhancer of drug sensitivity. Mol
Cancer Ther. 3:103–110. 2004.PubMed/NCBI
|
|
33
|
Göke R, Barth P, Schmidt A, Samans B and
Lankat-Buttgereit B: Programmed cell death protein 4 suppresses
CDK1/cdc2 via induction of p21 (Waf1/Cip1). Am J Physiol Cell
Physiol. 287:C1541–C1546. 2004. View Article : Google Scholar : PubMed/NCBI
|
